Results 201 to 210 of about 104,102 (262)

Effectiveness of antenatal intravenous immunoglobulin treatment in recurrent fetal and neonatal alloimmune thrombocytopenia. [PDF]

Ultrasound Obstet Gynecol
Zloto K, Cohen S, Batsry L, Schwartz A, Weissbach T, Avnet H, Weisz B, Yinon Y.   +7 more
europepmc   +1 more source

Intravenous immunoglobulin remodels innate immune cell communication and induces differential autophagy pathways in Kawasaki disease. [PDF]

Front Immunol
Singh SC, Retnakumar SV, Das M, Kaveri SV, Mathew MJ, Bayry J.   +5 more
europepmc   +1 more source

Successful intravenous immunoglobulin therapy in paraneoplastic pemphigus associated with hepatocellular carcinoma. [PDF]

An Bras Dermatol
Ramos J, Afonso C, Roda Â, Fonseca C.
europepmc   +1 more source

Infection Prophylaxis with Intravenous Immunoglobulin in Multiple Myeloma Patients Treated with Teclistamab.

Oncology
Sheu M, Molina Garcia S, Patel M, Mushtaq A, Rust T, Anns Asif M, Anwer F, Majeed A.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Intravenous Immunoglobulin and Fibrosis

Clinical Reviews in Allergy & Immunology, 2005
Fibrosis is a pathological process that includes scar formation and overproduction of extracellular matrix by the connective tissue as a response to tissue damage. Pathologies include pathological scarring as colloid and hypertrophic scars in the skin, cirrhosis of liver and gallbladder, pulmonary and bone-marrow fibrosis, and scleroderma.
Vered, Molina, Miri, Blank, Yehuda, Shoenfeld   +2 more
openaire   +2 more sources

Safety of Intravenous Immunoglobulin

Archives of Neurology, 1993
The current position of intravenous immunoglobulin (IVIG) in neurology is similar to that of plasmapheresis 10 years ago. Therapeutic claims have been made for an increasing number of neurologic disorders, based on small, uncontrolled studies. With the recent publication of a controlled trial of IVIG treatment in Guillain-Barre syndrome, 1 and trials ...
C A, Thornton, M, Ballow
openaire   +2 more sources

Intravenous Immunoglobulin and Atherosclerosis

Clinical Reviews in Allergy & Immunology, 2005
Several inflammatory and immunological factors have been established as important contributors to atherogenesis. Among these, oxidized low-density lipoprotein (oxLDL) play a central role in the initiation and progression of atherosclerotic lesions. In atherosclerotic lesions, oxLDL was also found to co-localize with beta2-glycoprotein I (beta2-GPI ...
Eiji, Matsuura, Kazuko, Kobayashi, Katsumi, Inoue, Yehuda, Shoenfeld   +3 more
openaire   +2 more sources

Therapeutic intravenous immunoglobulins

Molecular Immunology, 2005
Intravenous immunoglobulins (IVIg) are concentrated formulations of human IgG prepared by industrial fractionation of large pools of individual plasma donations. IVIg were developed 20 years ago for the prophylaxis support of immunodeficient patients.
Réal, Lemieux, Renée, Bazin, Sonia, Néron   +2 more
openaire   +2 more sources